Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00257088 · ClinicalTrials.gov registry record · Phase 4

The Whole Day First Grade Program

A Phase 4 study of Smoking, Tobacco and Prevention of Drug Abuse and Dependency, sponsored by American Institutes for Research.

Completed
Registry status
Phase 4
Development phase
2,000
Enrollment target
1
Study location

NCT00257088 is a Phase 4 study of Smoking, Tobacco and Prevention of Drug Abuse and Dependency that has completed, run by American Institutes for Research. The registered enrollment target is 2,000 participants, above the 519-participant average among 18 other Smoking, Tobacco trials with a reported enrollment target (285% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00257088, a Phase 4 study of Smoking, Tobacco and Prevention of Drug Abuse and Dependency, has completed, sponsored by American Institutes for Research.

COMPLETED
Registry status
Phase 4
Development phase
2,000 participants
Enrollment target
1
Study location

Study Summary

This five-year prevention services application is concerned with preventing substance abuse, comorbid mental and behavioral disorders, and school failure. We will direct an integrated set of first grade classroom based preventive interventions at two correlated and confirmed early antecedents: early aggressive, disruptive behavior and poor achievement. We will test a comprehensive Whole Day (WD) program directed at improving: 1) teacher's classroom behavior management; 2) family/classroom partnerships regarding homework and discipline; and 3) teacher's instructional practices regarding academic subjects, particularly reading. We will test WD effectiveness in a developmental epidemiological design in which children and teachers are randomly assigned to intervention and standard setting (control) classrooms in 2 classrooms in each of 12 schools. While following the first grade children to the end of third grade, we will follow their first grade teachers over two subsequent cohorts of first graders to test whether the support and training structure sustains high levels of WD practice. We will also test whether the support and training structure is successful in training non-WD teachers. This prevention services aim will be augmented by an economic analysis of the costs and cost-effectiveness of the WD program. This combined services and prevention research should increase the efficiency of developing evidence-based programs and extending their use system-wide in both the prevention and education fields. The aims of our proposed work are to: 1) Implement and evaluate the effectiveness of a whole-day preventive intervention program for first-grade (WD) directed at known antecedent risk factors for later substance abuse, school failure, and comorbid mental and behavioral disorders; 2) Measure the variation in impact of WD due to variation in the experimentally manipulated quality of teachers' specific WD practices around classroom behavior management, family/classroom par

Interventions

  • BEHAVIORAL whole day first grade program

Study Locations (1)

Maryland

  • AIR Center for Integrating Education and Prevention Research in Schools - Baltimore

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2003-09
Phase Phase 4

Sponsor

American Institutes for Research

2 total trials

What the Registry Record Tells You About NCT00257088

The ClinicalTrials.gov registry entry for NCT00257088 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 519-participant average among 18 other Smoking, Tobacco trials with a reported enrollment target (285% higher). The listed sponsor is American Institutes for Research, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Smoking, Tobacco appearing as the primary indexed condition, and to 1 intervention - of which whole day first grade program is the first listed.

NCT00257088 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00257088 about?

NCT00257088 is a clinical study titled "The Whole Day First Grade Program". This five-year prevention services application is concerned with preventing substance abuse, comorbid mental and behavioral disorders, and school failure. We will direct an integrated set of first grade classroom based preventive interventions at two correlated and confirmed early antecedents: early...

What is the current status of trial NCT00257088?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,000 participants. The study started on 2003-09.

What conditions does trial NCT00257088 study?

This clinical trial studies the following conditions: Smoking, Tobacco, Prevention of Drug Abuse and Dependency, Alcohol Abuse and Dependency, High Risk Sex Behavior, School Failure.

What interventions are being tested in trial NCT00257088?

The interventions under investigation include: whole day first grade program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00257088?

This trial is sponsored by American Institutes for Research, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00257088 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking, Tobacco

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.